SoftOx Solutions AS — Director's Dealing 2024

Sep 2, 2024

Mandatory notification of trade by primary insiders and close associates related to the Rights Issue.

Mandatory notification of trade by primary insiders and close associates related to the Rights Issue.

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

Reference is made to the stock exchange announcement published by SoftOx Solution AS (the "Company") earlier today, 2nd of September 2024, regarding the final results of the rights issue (the "Rights Issue").

The following primary insiders and close associates to primary insiders have been allocated new shares in the Rights Issue:

Bonica AS, a company owned by Ingrid Juven, the ICFO in the Company, has been allocated 67 678 282 shares in the Company. As a result, Ingrid Juven together with her fully owned company Bonica AS holds 85 178 282 shares in the Company.

The other primary insiders referred to in the stock notice 26.08.2024 are allocated shares in the Rights Issue according to the amount in the stock notice of 26.08.2024.

For any questions please contact:

Geir Almås, Chair of SoftOx Solutions AS

Mail: ir@soft-ox.com

Phone: Geir Almås: (+47) 977 59 071

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx) is a Medtech, and pharmaceutical company listed on Euronext Growth Oslo under 'SOFTX'. SoftOx Solutions AS was founded in 2012 and is headquartered in Oslo. The SoftOx Solutions Group includes the holding company SoftOx Solutions AS, the Malmö subsidiary Water Innovation AB, and subsidiaries SoftOx Defense Solutions AS and SoftOx Disinfection AS. SoftOx is developing a highly effective antimicrobial solution for biofilm, viral, and antimicrobial-resistant infections. The patent-protected technology is based on extensive research and development in partnership with leading Nordic research institutes.

For more information on SoftOx, visit www.soft-ox.com